Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2010
08/12/2010WO2010088924A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/12/2010WO2010088839A1 Drug membrane sticking to pants for treating prostatic hyperplasia and chronic prostatitis, and process for preparation thereof
08/12/2010WO2010088786A1 Herbal composition having cox-2 and immune activities and preparation method thereof
08/12/2010WO2009109616A8 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
08/12/2010US20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman
08/12/2010US20100204275 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/12/2010US20100204224 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels
08/12/2010US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors
08/12/2010US20100204185 Phenazopyridine compounds
08/12/2010US20100204182 Ectonucleotidase inhibitors
08/12/2010US20100204158 Combination of splenopentin and thymopentin and the use thereof in medicine
08/12/2010US20100204156 Use of thymopentin as a therapeutic agent
08/12/2010US20100204152 Use of gluten exorphin c : as a therapeutic agent
08/12/2010US20100204131 Use of a peptide as a therapeutic agent
08/12/2010US20100204124 Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
08/12/2010US20100204123 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
08/12/2010US20100204117 Cgrp as a therapeutic agent
08/12/2010US20100204116 Use of calcitonin as anti-angiogenic agent
08/12/2010US20100204115 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents
08/12/2010US20100204104 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor
08/12/2010US20100204094 Diuretic and natriuretic polypeptides
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203133 High drug load tablet
08/12/2010CA2751039A1 Pharmaceutical composition for oral administration
08/12/2010CA2741052A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient
08/11/2010EP2216031A1 Buffered Compositions for dialysis
08/11/2010EP2216025A2 Use of acylaminoalkenylene-amide derivatives in irritable bowel syndrome and functional dyspepsia
08/11/2010EP2216023A1 Condensed pyridine derivative and use thereof
08/11/2010EP2216021A1 Pharmaceutical composition for treating overactive bladder
08/11/2010EP2214688A2 Management and treatment of benign prostatic hyperplasia
08/11/2010EP2214686A1 Calcium-rich alkaline powder produced from processed molluse shells
08/11/2010EP1911763B1 Compositions for the treatment of gastrointestinal disorders
08/11/2010EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN101801949A Sulfonamides as TRPM8 modulators
08/11/2010CN101801379A CSF-1R inhibitors for treatment of cancer and bone diseases
08/11/2010CN101798300A N-phenylindole methyl substituted bis-benzimidazole derivative and application thereof in reducing blood pressure and the like
08/11/2010CN101797388A Matrix of suppository or paste medicine for treating prostatitis and preparation method thereof
08/11/2010CN101797285A Medical composition for preparing drug for curing nephritis
08/11/2010CN101797005A Preserved fruit capable of tonifying the kidney and arresting spontaneous emission
08/11/2010CN101204532B Medicine for prostate disease and preparation method thereof
08/11/2010CN101006047B TRPV1 agonists, formulations containing them and uses thereof
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772210 Cystitis treatment with high dose chondroitin sulfate
08/10/2010US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
08/10/2010US7771739 Implantable medical devices comprising semi-crystalline poly(ester-amide)
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2391832C Oral dosage forms
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/05/2010WO2010087709A1 Alanine-glyoxylate aminotransferase therapeutics
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087425A1 Prostate cancer progression inhibitor and progression inhibition method
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010039260A3 Spiperone derivatives and methods of treating disorders
08/05/2010WO2010012459A3 A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100197803 Method for obtaining a sequoyitol-containing extract from a plant of the genus of trifolium, leguminosae or ginkoaceae and uses thereof
08/05/2010US20100197744 Organic Compounds
08/05/2010US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS
08/05/2010US20100197710 Methods Of Activating IRS-1 And AKT
08/05/2010US20100197614 Treatment of urinary tract infections with a mixture of saponin and an antibiotic
08/05/2010US20100196518 Method and Device for the Treatment of Water for Purposes Conducive to Good Health
08/05/2010US20100196508 Method and composition for supplementation of nutritional deficiencies in renal patients
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196443 Use of cordyceps species or extract thereof in the egg production
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/05/2010US20100196345 Production of high mannose proteins in plant culture
08/05/2010US20100196340 Lactid acid bacteria as priobiotic strains and compositions containing same
08/05/2010CA2750811A1 Alanine-glyoxylate aminotransferase therapeutics
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213675A1 Pyridooxazepine derivative and use thereof
08/04/2010EP2211890A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins
08/04/2010EP2211875A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
08/04/2010EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases
08/04/2010CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795681A Method of preventing nephrocalcinosis
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/04/2010CN101791409A peptide vectors
08/04/2010CN101791389A Perineum medicine membrane underpants for treating prostatic hyperplasia and chronic prostatitis, perineum medicine membrane patch and preparation method
08/04/2010CN101791349A Chinese medicine preparation for treating prostatitis and preparation method thereof
08/04/2010CN101791318A Novel application of bacterial lipopolysaccharides
08/04/2010CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof
08/04/2010CN101791299A Method for preparing potassium citrate sustained-release tablets
08/03/2010US7767682 Treatment of renal diseases or conditions associated with abnormal ion flux in a mammal such as a human which comprises the administration of a hPPAR gamma modulator or salt or solvate thereof, such as farglitazar or rosiglitazone
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767665 1,3-benzothiazinone derivatives and use thereof
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases